Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Gaurav Kharya, MBBS, DCH, DNB
Indraprastha Apollo Hospitals
Delhi Mathura Road
New Delhi, Delhi, India
Dr. Gaurav Kharya is a Clinical Lead at Center for Bone Marrow Transplant and Cellular Therapy, Senior Consultant in pediatric hematology oncology and immunology at Indraprastha Apollo Hospitals, New Delhi. He completed his graduation from Netaji Subash Chandra Bose Medical College, Jabalpur Madhya Pradesh. Following this, he did his post-graduation DCH in pediatric from Baba Raghav Das Medical College, Gorakhpur, UP. In 2009, he joined his fellowship in pediatric hemato-oncology & BMT at Sir Ganga Ram Hospital which he completed in 2011.
Dr. Kharya has a vast experience in transplanting children with various blood disorders, benign or malignant, immunological diseases etc nationally and internationally. Dr. Kharya is credited for doing the first haploidentical bone marrow transplant for sickle cell disease in India & also for doing in-vitro TCR alpha beta CD 19 depleted haploidentical BMT in a 4 month old baby suffering from severe combined immunodeficiency who is the smallest child transplanted in the country so far.
Along with his team members at different centers, he has done more than 600 bone marrow transplants so far. His area of interest is alternative donor transplant such as haploidentical transplants and matched or mismatched unrelated donor transplants.
Edward J. Benz Jr., MDDr. Benz graduated from Harvard Medical ...
Olugbenga Olowokure, MDDr. Olugbenga Olowokure is a hematologis...
Caries prevalence and impact on oral health-related quality of life in children with sickle cell disease: cross-sect...BACKGROUND: Children with sickle cell di...
Provider Perspectives of Necessary Factors in Sickle Cell Disease Health Care Transition: Results from an Online Sur...Introduction: Survivorship of children w...
Providing Expert Care for Pregnant Sickle Cell Patienthttps://www.youtube.com/watch?v=rTebitxq...
Loma Linda University Medical CenterA new movement for patients who suffer f...
Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients Wi...Sancilio Pharmaceuticals Company, Inc. (...